JAK2 and cancer: Crytotanshinone (CPT) showed potential therapeutic value in animal breast model through enhancing cytotoxic CD4+ T cells by up-regulating JAK2 and STAT4 phosphorylation [30], suggesting that STAT4 may be play opposite function with STAT3 in human cancers.